401(k) · DOL Form 5500 · 2024
Xellia Pharmaceuticals 401(k) Plan
Data updated 2026-05-15
- $19M
- Total assets
- 375
- Participants
- 69th
- Percentile by assets
- $50,881
- Avg per participant
Sponsored by Xellia Pharmaceuticals USA LLC · Illinois · Manufacturing
What the 2024 filing shows
Xellia Pharmaceuticals 401(k) Plan holds $19M for 375 participants - about $50,881 per participant, above the median plan by assets, down 15.3% over the 2024 plan year.
- $19M
- total plan assets (2024 EOY)
- 375
- covered participants
- 69th
- percentile by assets (of 116,472 plans)
- $50,881
- avg assets per participant
The plan reported a net loss of $3M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.
401(k) · DOL Form 5500 · 2024
What the Filing Says About Xellia Pharmaceuticals 401(k) Plan
Xellia Pharmaceuticals 401(k) Plan is a 401(k) retirement plan sponsored by Xellia Pharmaceuticals USA LLC, headquartered in Illinois. According to the U.S. Department of Labor's 2024 Form 5500 filing, the plan reports $19M in total end-of-year assets and covers 375 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 471150410, and the plan has been effective since 2012-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets declined sharply from $23M at the beginning of 2024 to $19M at year-end - down 15.3%. Net assets (after liabilities) closed the year at $19M, with reported net income of -$3M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Across the 3 plan years Xellia Pharmaceuticals USA LLC has on file with PlainRetire (2022-2024), sponsor-wide plan assets have moved from $17M to $19M, a gain of 9.9%, while reported participants moved from 304 to 375 (+23.4%). The strongest year on file by total sponsor assets was 2023 at $23M; the softest was 2022 at $17M. Year-by-year, sponsor-wide filings show: 2022 - $17M in assets across 1 plan covering 304 participants; 2023 - $23M in assets across 1 plan covering 344 participants; 2024 - $19M in assets across 1 plan covering 375 participants.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows, a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
How the percentile is calculated: we count every plan that filed a 2024 Form 5500 with a reported end-of-year asset figure (116,472 plans), rank Xellia Pharmaceuticals 401(k) Plan against all of them by total assets, and report the share of those plans it outranks. A plan reporting no asset figure for the year is excluded from the ranking rather than assumed to be zero.
Financial Summary (2024)
| Total Assets (Beginning of Year) | $23M |
|---|---|
| Total Assets (End of Year) | $19M |
| Net Assets (End of Year) | $19M |
| Net Income | -$3M |
| Plan Type | 401(k) |
| Employer EIN | 471150410 |
| Plan Effective Date | 2012-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Xellia Pharmaceuticals USA LLC)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 304 | $17M |
| 2023 | 1 | 344 | $23M |
| 2024 | 1 | 375 | $19M |
Nearby 401(k) Plans in Illinois
Peer 401(k) plans, same state, same plan type, ranked by total assets.
- Accenture United States 401(k) Match and Savings Plan $21.3B · 66,965
- State Farm 401(k) Savings Plan $19.0B · 63,297
- United Airlines Pilot Retirement Account Plan $16.8B · 16,659
- Abbott Laboratories Stock Retirement Plan $15.8B · 38,229
- Walgreens Retirement Savings Plan $14.5B · 233,635
Frequently Asked Questions
How much money is in the Xellia Pharmaceuticals 401(k) Plan? ▼
What type of plan is Xellia Pharmaceuticals 401(k) Plan? ▼
Who sponsors the Xellia Pharmaceuticals 401(k) Plan? ▼
How did Xellia Pharmaceuticals 401(k) Plan perform in 2024? ▼
What this filing means
Ways to act on Xellia Pharmaceuticals 401(k) Plan's numbers.
- By total assets, Xellia Pharmaceuticals 401(k) Plan ranks above the median plan by assets. See the largest plans
- Compare it side-by-side against 3 similar 401(k) plans in Illinois. Compare plans
- Xellia Pharmaceuticals USA LLC's sponsor-wide assets have grown 9.9% since 2022 across 3 plan years on file. More Manufacturing plans
- A 401(k) plan works differently from other retirement plan types, understand the structural differences before comparing. Compare plan types
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2024.
Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 471150410.
Reference: IRS Publication 560, Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B, Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainRetire is rendered directly from the Department of Labor's Form 5500 annual return filings, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15.